Company intelligence / Profile preview

Silver River International Investment

Hong Kong, Hong Kong

Ownership: Private
Development stage: Other

Overview

Silver River International Investment is a private investment firm focused on the global life sciences and healthcare sectors. The firm provides strategic growth capital to biotechnology and pharmaceutical companies, particularly those developing innovative therapies for oncology, immunology, and other high-unmet-need areas. Silver River has been a notable investor in several prominent biotech companies, including Harbour BioMed, Connect Biopharma, and Cullinan Oncology. The firm typically engages in late-stage private equity rounds and crossover investments, supporting companies through their initial public offerings and beyond.

Industry: Investors

Partnerships

Advantech Capital

Beyond the preview

Go deeper on Silver River International Investment.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Silver River International Investment.

Explore the full profile